Microbiologics Introduces SARS-CoV-2 Products for Quality Control and Research
The company’s latest covid-19 products include a protein-coated RNA process control, and an in vitro diagnostics control with pooled gene targets.
Read MorePosted by Laurie Bonner | May 8, 2020 | Covid 19 |
The company’s latest covid-19 products include a protein-coated RNA process control, and an in vitro diagnostics control with pooled gene targets.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
In the United States, the digital pathology software will support the need for remote pathology brought about by the covid-19 pandemic.
Read MorePosted by | May 6, 2020 | Covid 19, Digital Pathology, Emerging & Zoonotic Diseases, Infectious Diseases, Mounting Systems & Substrates |
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services.
Read MorePosted by | May 6, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases, Printers, Swabs |
The quickest-to-produce swabs consist of a single plastic material from tip to tip, with a lattice or a honey dipper design to collect a sample at one end.
Read MorePosted by | May 4, 2020 | Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
Clinical evaluation of Bio-Rad’s SARS-CoV-2 total antibody test has demonstrated diagnostic specificity of more than 99% and sensitivity of 98%.
Read More